Axonex AI Group Limited Class A (AXNX)
NASDAQ: AXNXConsumer DiscretionaryBusiness ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AXNX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.28M
- EPS (TTM)
- -$10.37
- Dividend yield
- None
- 52-week range
- 0.68 – 18.35
- Day range
- 0.83 – 0.9435
- Volume / Avg
- 26.95K / 2.01M
- Beta
- —
- Shares outstanding
- 6.08M
52-week range
AXNX stock today
Axonex AI Group (AXNX) closed at $0.8301 on Nov 20, down 8.28% (-$0.0749), versus the S&P 500's 3.70% decline. Trading was light, with 26.95K shares changing hands, about 1% of the average daily volume. Shares are 95.5% below their 52-week high of $18.35 and 22.1% above the 52-week low of $0.68, near the bottom of the past year's range.
Axonex AI Group has posted a net loss over the last twelve months (EPS of -$10.37), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Axonex AI Group
Company profileAxonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence.
- Sector
- Consumer Discretionary
- Industry
- Business Services
- CEO
- Mr. Raymond W. Cohen
- Headquarters
- Irvine, CA
- Employees
- 797
- IPO year
- 2025
- Website
- axonics.com
Financial highlights
Full financialsAxonex AI Group reported a net loss of $10.3 million, compared with a loss of $1.5 million a year earlier. Diluted earnings per share came in at -$4.15.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue | — | $3.05M | $4.08M | $2.44M |
| Growth | — | -25.28% | +67.36% | — |
| Net income | $-10.31M | $-1.46M | $783.44K | $819.42K |
| EPS (diluted) | $-4.15 | $-0.68 | $0.37 | $0.04 |
Analyst forecast
ForecastConsensus (5 analysts)
hold
- Strong buy 0
- Buy 1
- Hold 4
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
AXNX news
All AXNX newsAxonex AI Group peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRKR36Kr Holdings Inc. ADR | 2.56 | -3.40% | $5.05M | vs AXNX |
| BAOSBaosheng Media Group Holdings Limited | 0.1166 | -8.91% | $3.89M | vs AXNX |
| OLBThe OLB Group Inc. | 0.115 | -4.33% | $3.59M | vs AXNX |
| TGLTreasure Global Inc. | 3.88 | -5.13% | $3.56M | vs AXNX |
| CJMBCallan JMB Inc. | 0.301 | -7.10% | $3.21M | vs AXNX |
| QHQuhuo Limited Class A | 3.06 | -1.29% | $8.42M | vs AXNX |
| UKUcommune International Ltd Class A | 1.10 | -9.84% | $745.75K | vs AXNX |
| XHLDTEN Holdings Inc. | 0.6402 | -3.03% | $9.90M | vs AXNX |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Axonex AI Group stock FAQ
What is Axonex AI Group's stock price today?
AXNX last traded at $0.8301 as of Nov 20, 4:00 PM EST, down 8.28% on the day. Prices are delayed at least 15 minutes.
Does Axonex AI Group pay a dividend?
No. Axonex AI Group does not currently pay a regular cash dividend.
Who is Axonex AI Group's CEO?
Mr. Raymond W. Cohen is the chief executive officer of Axonex AI Group Limited Class A, which has about 797 employees.
Has AXNX ever split its stock?
Yes. The most recent AXNX stock split was a 1-for-3 split on Oct 22, 2026.
What is the AXNX 52-week high?
The 52-week high for AXNX is $18.35 and the 52-week low is $0.68. The stock is currently 95.5% below its high.